Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1i3
|
ENSMUSG00000005677.8 | Nr1i3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Nr1i3 | chr1_171214344_171214599 | 122 | 0.903216 | 0.26 | 4.4e-02 | Click! |
Nr1i3 | chr1_171212888_171213039 | 1007 | 0.293380 | 0.22 | 9.0e-02 | Click! |
Nr1i3 | chr1_171214072_171214327 | 150 | 0.886111 | 0.18 | 1.7e-01 | Click! |
Nr1i3 | chr1_171214649_171214822 | 386 | 0.676463 | 0.15 | 2.4e-01 | Click! |
Nr1i3 | chr1_171214883_171215087 | 636 | 0.469340 | 0.15 | 2.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_32296600_32297646 | 19.46 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
495 |
0.66 |
chr11_102360845_102363484 | 16.29 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr11_102145120_102148094 | 16.25 |
Nags |
N-acetylglutamate synthase |
241 |
0.58 |
chr11_32283784_32284776 | 15.94 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
469 |
0.66 |
chr10_25458395_25459149 | 15.40 |
Epb41l2 |
erythrocyte membrane protein band 4.1 like 2 |
8201 |
0.21 |
chr15_103253562_103255772 | 13.23 |
Nfe2 |
nuclear factor, erythroid derived 2 |
605 |
0.57 |
chr2_173024069_173026002 | 13.02 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr4_154926952_154928851 | 12.69 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr19_10015065_10016667 | 12.53 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr3_14889110_14890285 | 12.17 |
Car2 |
carbonic anhydrase 2 |
3058 |
0.25 |
chr8_80497324_80498362 | 11.84 |
Gypa |
glycophorin A |
4062 |
0.27 |
chr5_64810297_64813272 | 11.75 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr4_119189472_119189950 | 11.69 |
Ermap |
erythroblast membrane-associated protein |
240 |
0.84 |
chr2_28619027_28619457 | 11.67 |
Gfi1b |
growth factor independent 1B |
2703 |
0.16 |
chr16_18429039_18430122 | 11.54 |
Txnrd2 |
thioredoxin reductase 2 |
655 |
0.54 |
chr9_44340460_44342952 | 11.13 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr4_46040988_46042013 | 11.07 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chr4_136175795_136176646 | 11.05 |
E2f2 |
E2F transcription factor 2 |
3826 |
0.17 |
chr6_55336550_55338274 | 10.53 |
Aqp1 |
aquaporin 1 |
980 |
0.5 |
chr2_155612818_155614078 | 10.52 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
2236 |
0.14 |
chr3_153908033_153909893 | 10.50 |
Snord45b |
small nucleolar RNA, C/D box 45B |
1670 |
0.17 |
chrX_7966827_7967869 | 10.27 |
Gata1 |
GATA binding protein 1 |
562 |
0.55 |
chr14_70625458_70627688 | 9.99 |
Dmtn |
dematin actin binding protein |
418 |
0.75 |
chr1_173332160_173333204 | 9.97 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
820 |
0.54 |
chr18_32557788_32558922 | 9.69 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr5_123131617_123134965 | 9.60 |
Rhof |
ras homolog family member F (in filopodia) |
599 |
0.36 |
chr8_84703616_84705950 | 9.47 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr7_143005720_143007083 | 9.40 |
Tspan32 |
tetraspanin 32 |
473 |
0.68 |
chr18_35847749_35850271 | 9.09 |
Cxxc5 |
CXXC finger 5 |
5677 |
0.11 |
chr8_122546551_122549259 | 9.04 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr1_136945385_136947968 | 8.92 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
2497 |
0.34 |
chr7_100465236_100467118 | 8.91 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr18_62176067_62177775 | 8.82 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr4_130173825_130175545 | 8.81 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
6 |
0.97 |
chr5_137569837_137570642 | 8.80 |
Tfr2 |
transferrin receptor 2 |
370 |
0.67 |
chr7_45574320_45575183 | 8.72 |
Bcat2 |
branched chain aminotransferase 2, mitochondrial |
349 |
0.43 |
chr6_55338294_55340060 | 8.67 |
Aqp1 |
aquaporin 1 |
2745 |
0.22 |
chr8_111573318_111574249 | 8.67 |
Znrf1 |
zinc and ring finger 1 |
11943 |
0.18 |
chr11_102363631_102364272 | 8.67 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
247 |
0.85 |
chr17_29657893_29658263 | 8.65 |
Gm20161 |
predicted gene, 20161 |
258 |
0.85 |
chr11_120628644_120631479 | 8.63 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
87 |
0.89 |
chr15_77753662_77753974 | 8.59 |
Apol8 |
apolipoprotein L 8 |
1421 |
0.26 |
chrX_9275213_9275657 | 8.59 |
Xk |
X-linked Kx blood group |
2679 |
0.18 |
chr1_171225202_171226411 | 8.56 |
Apoa2 |
apolipoprotein A-II |
715 |
0.4 |
chr2_103958009_103958847 | 8.31 |
Lmo2 |
LIM domain only 2 |
433 |
0.78 |
chr7_115844628_115845173 | 8.21 |
Sox6 |
SRY (sex determining region Y)-box 6 |
1205 |
0.62 |
chr17_40810971_40811398 | 8.19 |
Rhag |
Rhesus blood group-associated A glycoprotein |
0 |
0.97 |
chr12_111442182_111444685 | 8.05 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
771 |
0.51 |
chr11_102364387_102365146 | 7.99 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
481 |
0.67 |
chr5_120138122_120139268 | 7.99 |
Gm10390 |
predicted gene 10390 |
566 |
0.77 |
chr7_100492685_100494805 | 7.96 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chr17_34998907_34999597 | 7.90 |
Vars |
valyl-tRNA synthetase |
1735 |
0.11 |
chr8_23035959_23037041 | 7.90 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr10_80856664_80858456 | 7.65 |
Sppl2b |
signal peptide peptidase like 2B |
439 |
0.61 |
chr8_120292266_120293650 | 7.62 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
64502 |
0.09 |
chr13_45512026_45513101 | 7.60 |
Gmpr |
guanosine monophosphate reductase |
1277 |
0.51 |
chr19_32237775_32238144 | 7.53 |
Sgms1 |
sphingomyelin synthase 1 |
853 |
0.67 |
chr19_5842574_5845856 | 7.51 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr11_87756102_87757558 | 7.49 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr11_98581326_98581888 | 7.49 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
5761 |
0.11 |
chr2_127369985_127371247 | 7.46 |
Adra2b |
adrenergic receptor, alpha 2b |
7330 |
0.15 |
chr16_76323454_76323665 | 7.29 |
Nrip1 |
nuclear receptor interacting protein 1 |
99 |
0.98 |
chr15_103250315_103251530 | 7.26 |
Nfe2 |
nuclear factor, erythroid derived 2 |
543 |
0.62 |
chr2_32081622_32082932 | 7.21 |
Fam78a |
family with sequence similarity 78, member A |
1506 |
0.26 |
chr6_72391190_72391463 | 7.21 |
Vamp8 |
vesicle-associated membrane protein 8 |
623 |
0.55 |
chr4_46453910_46454934 | 7.20 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
3520 |
0.17 |
chrX_150547515_150548479 | 7.13 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
538 |
0.44 |
chr7_45523041_45524800 | 7.09 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr8_84836764_84838739 | 7.06 |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
296 |
0.75 |
chr9_103286971_103287430 | 7.02 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
1024 |
0.5 |
chr2_4562127_4563316 | 7.00 |
Frmd4a |
FERM domain containing 4A |
2946 |
0.28 |
chr8_94985013_94985221 | 6.95 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
451 |
0.73 |
chr7_142576289_142578620 | 6.95 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr4_63153559_63154085 | 6.94 |
Ambp |
alpha 1 microglobulin/bikunin precursor |
351 |
0.86 |
chr8_84701273_84703379 | 6.93 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr19_29126810_29127736 | 6.88 |
Mir101b |
microRNA 101b |
8006 |
0.14 |
chr7_113295089_113296008 | 6.88 |
Gm45355 |
predicted gene 45355 |
211 |
0.93 |
chr3_101551232_101552184 | 6.80 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
25852 |
0.16 |
chr8_94986231_94987228 | 6.77 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
1161 |
0.36 |
chr5_137570868_137571950 | 6.76 |
Tfr2 |
transferrin receptor 2 |
42 |
0.93 |
chr11_95778707_95778988 | 6.75 |
Polr2k-ps |
polymerase (RNA) II (DNA directed) polypeptide K, pseudogene |
17356 |
0.11 |
chr15_76249292_76250521 | 6.65 |
Mir6953 |
microRNA 6953 |
1715 |
0.14 |
chrX_85613609_85614890 | 6.64 |
Gm44378 |
predicted gene, 44378 |
25272 |
0.18 |
chr10_75937829_75938478 | 6.63 |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
933 |
0.28 |
chr9_72410185_72410545 | 6.59 |
BC065403 |
cDNA sequence BC065403 |
420 |
0.6 |
chr7_99594627_99596228 | 6.58 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr11_96942711_96943051 | 6.55 |
Pnpo |
pyridoxine 5'-phosphate oxidase |
898 |
0.32 |
chr1_174173964_174174767 | 6.53 |
Spta1 |
spectrin alpha, erythrocytic 1 |
1589 |
0.22 |
chr11_75165245_75169157 | 6.52 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr6_60826003_60826617 | 6.50 |
Snca |
synuclein, alpha |
1246 |
0.48 |
chr11_97439854_97442222 | 6.49 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr19_5724785_5726881 | 6.47 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr5_119685576_119687800 | 6.36 |
Tbx3os2 |
T-box 3, opposite strand 2 |
4530 |
0.17 |
chr7_75612178_75613652 | 6.31 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr8_94985246_94986199 | 6.31 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
154 |
0.93 |
chr1_125676834_125678312 | 6.30 |
Gpr39 |
G protein-coupled receptor 39 |
578 |
0.8 |
chr14_66279066_66281333 | 6.28 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr19_5724002_5724609 | 6.28 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
1965 |
0.11 |
chr4_132075821_132077656 | 6.26 |
Epb41 |
erythrocyte membrane protein band 4.1 |
1417 |
0.25 |
chr9_40323395_40324376 | 6.25 |
1700110K17Rik |
RIKEN cDNA 1700110K17 gene |
459 |
0.71 |
chr8_123978308_123979538 | 6.24 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4199 |
0.12 |
chr2_26485135_26488628 | 6.22 |
Notch1 |
notch 1 |
16383 |
0.09 |
chrX_101377313_101377922 | 6.22 |
Gjb1 |
gap junction protein, beta 1 |
344 |
0.84 |
chr6_5255342_5256653 | 6.19 |
Pon3 |
paraoxonase 3 |
217 |
0.93 |
chr17_29493756_29495031 | 6.17 |
Pim1 |
proviral integration site 1 |
986 |
0.37 |
chr19_45447201_45447888 | 6.11 |
Btrc |
beta-transducin repeat containing protein |
2036 |
0.3 |
chr11_116076531_116078496 | 6.10 |
Unc13d |
unc-13 homolog D |
77 |
0.94 |
chr14_69269425_69270999 | 6.08 |
Gm27222 |
predicted gene 27222 |
11066 |
0.09 |
chr11_97434598_97436859 | 6.02 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr6_83068298_83071797 | 6.01 |
Tlx2 |
T cell leukemia, homeobox 2 |
178 |
0.81 |
chr13_37965323_37966006 | 5.99 |
Rreb1 |
ras responsive element binding protein 1 |
18648 |
0.17 |
chr6_48676062_48676718 | 5.97 |
Gimap9 |
GTPase, IMAP family member 9 |
261 |
0.79 |
chr4_106804374_106805428 | 5.93 |
Acot11 |
acyl-CoA thioesterase 11 |
97 |
0.96 |
chr1_173331444_173331908 | 5.91 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
1826 |
0.27 |
chr2_121235231_121235799 | 5.90 |
Trp53bp1 |
transformation related protein 53 binding protein 1 |
174 |
0.93 |
chr17_79350765_79351583 | 5.90 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
1833 |
0.37 |
chr6_58642449_58642948 | 5.89 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
2116 |
0.36 |
chr6_86078066_86079298 | 5.89 |
Add2 |
adducin 2 (beta) |
598 |
0.65 |
chr7_19082814_19086200 | 5.88 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr17_85686512_85689764 | 5.88 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr10_77112255_77113959 | 5.88 |
Col18a1 |
collagen, type XVIII, alpha 1 |
598 |
0.73 |
chr14_70624394_70624692 | 5.87 |
Dmtn |
dematin actin binding protein |
1612 |
0.25 |
chr2_9882196_9886301 | 5.87 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr19_45446379_45446948 | 5.86 |
Btrc |
beta-transducin repeat containing protein |
1155 |
0.47 |
chr3_95673620_95674691 | 5.85 |
Adamtsl4 |
ADAMTS-like 4 |
2996 |
0.14 |
chr3_144198213_144200687 | 5.83 |
Gm43445 |
predicted gene 43445 |
188 |
0.94 |
chr9_21963175_21963912 | 5.81 |
Epor |
erythropoietin receptor |
37 |
0.94 |
chr2_91096772_91098746 | 5.80 |
Spi1 |
spleen focus forming virus (SFFV) proviral integration oncogene |
979 |
0.4 |
chr11_69364290_69367679 | 5.79 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
1205 |
0.24 |
chr11_53422380_53423106 | 5.76 |
Leap2 |
liver-expressed antimicrobial peptide 2 |
427 |
0.66 |
chr9_21835562_21836256 | 5.76 |
Angptl8 |
angiopoietin-like 8 |
399 |
0.73 |
chr9_108095812_108096242 | 5.73 |
Apeh |
acylpeptide hydrolase |
1421 |
0.18 |
chr11_96343236_96346574 | 5.70 |
Hoxb3 |
homeobox B3 |
1136 |
0.24 |
chr6_83247659_83247969 | 5.70 |
Slc4a5 |
solute carrier family 4, sodium bicarbonate cotransporter, member 5 |
10439 |
0.12 |
chr5_107866349_107866649 | 5.70 |
Evi5 |
ecotropic viral integration site 5 |
1889 |
0.18 |
chr7_133702217_133702505 | 5.70 |
Uros |
uroporphyrinogen III synthase |
177 |
0.91 |
chr17_28007198_28009699 | 5.70 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
1103 |
0.37 |
chr5_139390751_139391547 | 5.66 |
Gpr146 |
G protein-coupled receptor 146 |
1364 |
0.29 |
chr1_165768492_165768993 | 5.63 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
734 |
0.46 |
chr17_48449646_48450503 | 5.63 |
Tspo2 |
translocator protein 2 |
1 |
0.96 |
chr10_93890810_93891154 | 5.62 |
Metap2 |
methionine aminopeptidase 2 |
147 |
0.93 |
chr2_28620746_28622145 | 5.61 |
Gfi1b |
growth factor independent 1B |
500 |
0.68 |
chrX_12151122_12152833 | 5.60 |
Bcor |
BCL6 interacting corepressor |
8369 |
0.25 |
chr11_102358807_102359649 | 5.57 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1340 |
0.27 |
chr5_143625482_143626083 | 5.56 |
Cyth3 |
cytohesin 3 |
3248 |
0.24 |
chr1_40771505_40772300 | 5.53 |
Gm37915 |
predicted gene, 37915 |
517 |
0.75 |
chr16_92824618_92824960 | 5.53 |
Runx1 |
runt related transcription factor 1 |
989 |
0.64 |
chr11_78072614_78073453 | 5.51 |
Mir144 |
microRNA 144 |
28 |
0.51 |
chr10_59403301_59404650 | 5.50 |
Pla2g12b |
phospholipase A2, group XIIB |
315 |
0.88 |
chr11_57646820_57647221 | 5.50 |
Galnt10 |
polypeptide N-acetylgalactosaminyltransferase 10 |
1555 |
0.31 |
chr16_90738322_90739000 | 5.50 |
Mrap |
melanocortin 2 receptor accessory protein |
337 |
0.85 |
chr5_114969022_114970855 | 5.49 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
18 |
0.91 |
chr14_76532606_76533942 | 5.49 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6658 |
0.2 |
chr7_133700764_133701966 | 5.48 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr9_103229120_103230944 | 5.48 |
Trf |
transferrin |
234 |
0.92 |
chr4_124606574_124606932 | 5.47 |
4933407E24Rik |
RIKEN cDNA 4933407E24 gene |
37563 |
0.1 |
chr8_84722866_84724458 | 5.47 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
655 |
0.54 |
chr12_78904719_78905643 | 5.46 |
Plek2 |
pleckstrin 2 |
1783 |
0.34 |
chr15_78403325_78404519 | 5.46 |
Tst |
thiosulfate sulfurtransferase, mitochondrial |
1930 |
0.17 |
chr1_160987520_160988086 | 5.45 |
Serpinc1 |
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
716 |
0.38 |
chr5_88594081_88594831 | 5.45 |
Rufy3 |
RUN and FYVE domain containing 3 |
10662 |
0.16 |
chr11_103102696_103105788 | 5.45 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr2_32080366_32081236 | 5.45 |
Fam78a |
family with sequence similarity 78, member A |
1449 |
0.27 |
chr14_69487673_69488235 | 5.44 |
Gm37094 |
predicted gene, 37094 |
12436 |
0.1 |
chr9_103286549_103286733 | 5.44 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
1583 |
0.35 |
chr2_84939414_84939569 | 5.43 |
Slc43a3 |
solute carrier family 43, member 3 |
2601 |
0.19 |
chr13_3891572_3893506 | 5.42 |
Net1 |
neuroepithelial cell transforming gene 1 |
894 |
0.46 |
chr7_44350602_44354420 | 5.42 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1749 |
0.15 |
chr5_122018591_122019443 | 5.42 |
Gm3970 |
predicted gene 3970 |
6313 |
0.16 |
chrX_103448739_103449535 | 5.39 |
Tsix |
X (inactive)-specific transcript, opposite strand |
1415 |
0.24 |
chr17_12378732_12379615 | 5.38 |
Plg |
plasminogen |
514 |
0.75 |
chr7_31114363_31115023 | 5.38 |
Hpn |
hepsin |
582 |
0.56 |
chr13_73468941_73470244 | 5.38 |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
2159 |
0.35 |
chr11_119671641_119671869 | 5.36 |
Rptor |
regulatory associated protein of MTOR, complex 1 |
15811 |
0.17 |
chr17_48300015_48301474 | 5.35 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr13_45507294_45508710 | 5.35 |
Gmpr |
guanosine monophosphate reductase |
558 |
0.8 |
chr2_84735706_84738103 | 5.35 |
Ypel4 |
yippee like 4 |
2677 |
0.11 |
chr2_38531311_38531917 | 5.34 |
Gm35808 |
predicted gene, 35808 |
4093 |
0.15 |
chr1_120269326_120269674 | 5.33 |
Steap3 |
STEAP family member 3 |
923 |
0.66 |
chr13_96698022_96698314 | 5.32 |
Gm48575 |
predicted gene, 48575 |
20045 |
0.14 |
chr6_31612888_31614126 | 5.32 |
Gm43154 |
predicted gene 43154 |
8218 |
0.19 |
chr8_25191902_25192495 | 5.31 |
Tacc1 |
transforming, acidic coiled-coil containing protein 1 |
8345 |
0.18 |
chr9_72448745_72450029 | 5.31 |
Gm27231 |
predicted gene 27231 |
7608 |
0.08 |
chr14_55061871_55064122 | 5.30 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr16_91805843_91806547 | 5.30 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
1559 |
0.38 |
chr11_102308792_102311562 | 5.29 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
269 |
0.84 |
chr7_143007094_143009025 | 5.28 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr16_32176859_32178095 | 5.28 |
Bex6 |
brain expressed family member 6 |
2346 |
0.2 |
chr10_62341499_62342686 | 5.27 |
Hk1 |
hexokinase 1 |
607 |
0.63 |
chr4_154024404_154026596 | 5.26 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr11_102895188_102895912 | 5.25 |
Gfap |
glial fibrillary acidic protein |
1581 |
0.23 |
chr5_66080287_66081072 | 5.24 |
Rbm47 |
RNA binding motif protein 47 |
305 |
0.84 |
chr2_121035039_121035972 | 5.23 |
Epb42 |
erythrocyte membrane protein band 4.2 |
1176 |
0.33 |
chr19_56287823_56288746 | 5.18 |
Habp2 |
hyaluronic acid binding protein 2 |
288 |
0.91 |
chr5_123933769_123934484 | 5.16 |
Ccdc62 |
coiled-coil domain containing 62 |
3437 |
0.14 |
chr9_66988141_66989423 | 5.16 |
Gm24225 |
predicted gene, 24225 |
7597 |
0.16 |
chr5_35160468_35161280 | 5.15 |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
55108 |
0.11 |
chr4_130171697_130173536 | 5.15 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
2075 |
0.27 |
chrX_77432774_77434116 | 5.15 |
Gm5937 |
predicted gene 5937 |
23141 |
0.22 |
chr8_109865527_109866018 | 5.14 |
Gm17344 |
predicted gene, 17344 |
2660 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 25.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
5.8 | 17.3 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
5.7 | 17.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
4.8 | 14.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
4.7 | 4.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
4.7 | 23.4 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
4.2 | 104.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
4.1 | 16.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
4.0 | 8.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
4.0 | 12.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.9 | 15.7 | GO:1900211 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
3.8 | 7.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
3.8 | 15.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.7 | 7.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
3.7 | 3.7 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
3.6 | 3.6 | GO:1901656 | glycoside transport(GO:1901656) |
3.6 | 10.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
3.4 | 17.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
3.3 | 77.0 | GO:0048821 | erythrocyte development(GO:0048821) |
3.2 | 19.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
3.2 | 9.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
3.2 | 15.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
3.2 | 25.4 | GO:0097286 | iron ion import(GO:0097286) |
3.1 | 25.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
3.1 | 9.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
3.0 | 9.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.9 | 8.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.9 | 14.4 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
2.8 | 5.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.7 | 5.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.7 | 8.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
2.7 | 8.1 | GO:0046618 | drug export(GO:0046618) |
2.7 | 8.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.6 | 7.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.6 | 15.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.5 | 10.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
2.5 | 2.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
2.5 | 10.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.5 | 2.5 | GO:0097503 | sialylation(GO:0097503) |
2.4 | 9.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
2.4 | 7.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.4 | 4.8 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
2.4 | 12.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
2.4 | 9.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.4 | 7.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.4 | 7.1 | GO:0000087 | mitotic M phase(GO:0000087) |
2.3 | 7.0 | GO:0002432 | granuloma formation(GO:0002432) |
2.3 | 16.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
2.3 | 2.3 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.3 | 6.8 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.2 | 9.0 | GO:0032264 | IMP salvage(GO:0032264) |
2.2 | 4.5 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
2.2 | 6.7 | GO:0061511 | centriole elongation(GO:0061511) |
2.2 | 4.4 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
2.2 | 4.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.2 | 4.3 | GO:0015684 | ferrous iron transport(GO:0015684) |
2.1 | 4.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
2.1 | 10.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
2.1 | 4.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.1 | 6.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
2.1 | 6.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.1 | 10.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.1 | 6.2 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
2.1 | 4.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
2.1 | 10.4 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
2.1 | 6.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.1 | 4.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.0 | 6.1 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
2.0 | 6.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.0 | 6.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
2.0 | 6.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.0 | 4.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.0 | 11.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.9 | 7.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.9 | 9.6 | GO:0015879 | carnitine transport(GO:0015879) |
1.9 | 1.9 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.9 | 7.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.9 | 13.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.9 | 3.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.9 | 11.3 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.9 | 3.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.8 | 5.5 | GO:0036394 | amylase secretion(GO:0036394) |
1.8 | 3.6 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.8 | 9.0 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.8 | 31.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.8 | 5.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.8 | 3.5 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
1.8 | 1.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.7 | 5.2 | GO:0035483 | gastric emptying(GO:0035483) |
1.7 | 7.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.7 | 10.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.7 | 12.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.7 | 3.5 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.7 | 8.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.7 | 3.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.7 | 5.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
1.7 | 12.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.7 | 5.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.7 | 5.1 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
1.7 | 6.8 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.7 | 5.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.7 | 3.4 | GO:0015677 | copper ion import(GO:0015677) |
1.7 | 5.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.7 | 5.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.7 | 13.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.7 | 1.7 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
1.7 | 6.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.6 | 14.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.6 | 1.6 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
1.6 | 1.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.6 | 4.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.6 | 6.5 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.6 | 1.6 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
1.6 | 3.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.6 | 8.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
1.6 | 9.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.6 | 1.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.6 | 6.4 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.6 | 4.8 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.6 | 8.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.6 | 23.6 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.6 | 4.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.6 | 3.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.6 | 4.7 | GO:0001798 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
1.6 | 1.6 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
1.6 | 12.5 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
1.6 | 3.1 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
1.5 | 6.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.5 | 4.6 | GO:0042117 | monocyte activation(GO:0042117) |
1.5 | 4.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.5 | 1.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.5 | 4.5 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.5 | 4.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.5 | 4.5 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.5 | 3.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.5 | 6.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.5 | 7.5 | GO:0032602 | chemokine production(GO:0032602) |
1.5 | 1.5 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
1.5 | 8.9 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
1.5 | 10.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.5 | 4.4 | GO:0008228 | opsonization(GO:0008228) |
1.5 | 1.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.5 | 4.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.4 | 5.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.4 | 20.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.4 | 7.2 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.4 | 11.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.4 | 1.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.4 | 4.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.4 | 9.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.4 | 12.6 | GO:0070269 | pyroptosis(GO:0070269) |
1.4 | 5.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.4 | 4.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.4 | 4.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.4 | 9.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.4 | 1.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.4 | 6.9 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.4 | 26.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.4 | 4.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.3 | 5.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.3 | 4.0 | GO:0061010 | gall bladder development(GO:0061010) |
1.3 | 5.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.3 | 6.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.3 | 4.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.3 | 10.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.3 | 2.6 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
1.3 | 6.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.3 | 3.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.3 | 5.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.3 | 2.6 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.3 | 3.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.3 | 2.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.3 | 3.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.3 | 6.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.3 | 5.2 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
1.3 | 3.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.3 | 3.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.3 | 3.8 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.3 | 3.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.3 | 3.8 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.3 | 2.5 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.3 | 2.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.2 | 5.0 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
1.2 | 3.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.2 | 3.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.2 | 2.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.2 | 3.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.2 | 2.5 | GO:0002254 | kinin cascade(GO:0002254) |
1.2 | 3.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.2 | 3.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.2 | 18.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.2 | 1.2 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
1.2 | 3.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.2 | 14.5 | GO:0046697 | decidualization(GO:0046697) |
1.2 | 3.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.2 | 4.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.2 | 10.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.2 | 10.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
1.2 | 2.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.2 | 3.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.2 | 5.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.2 | 3.5 | GO:0019532 | oxalate transport(GO:0019532) |
1.2 | 3.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.2 | 4.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.2 | 1.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.2 | 4.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.2 | 2.3 | GO:0032782 | bile acid secretion(GO:0032782) |
1.2 | 4.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.2 | 4.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.1 | 4.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.1 | 2.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.1 | 3.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 4.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.1 | 1.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.1 | 1.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.1 | 8.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.1 | 4.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.1 | 7.9 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.1 | 5.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.1 | 1.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.1 | 12.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.1 | 1.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.1 | 7.8 | GO:0015825 | L-serine transport(GO:0015825) |
1.1 | 7.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.1 | 10.0 | GO:0045730 | respiratory burst(GO:0045730) |
1.1 | 8.9 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.1 | 3.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.1 | 2.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.1 | 10.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.1 | 5.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
1.1 | 2.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.1 | 4.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
1.1 | 4.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.1 | 16.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.1 | 26.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.1 | 5.5 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.1 | 1.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
1.1 | 3.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.1 | 6.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.1 | 1.1 | GO:0036258 | multivesicular body assembly(GO:0036258) |
1.1 | 13.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.1 | 1.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.1 | 4.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.1 | 5.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.1 | 7.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.1 | 3.2 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
1.1 | 1.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.1 | 3.2 | GO:0018343 | protein farnesylation(GO:0018343) |
1.1 | 2.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.1 | 3.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.1 | 2.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.0 | 2.1 | GO:0051029 | rRNA transport(GO:0051029) |
1.0 | 7.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.0 | 2.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.0 | 4.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.0 | 5.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.0 | 5.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.0 | 2.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
1.0 | 6.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.0 | 8.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.0 | 1.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
1.0 | 2.0 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.0 | 2.0 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
1.0 | 1.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.0 | 5.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.0 | 1.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.0 | 3.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.0 | 6.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.0 | 2.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
1.0 | 7.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.0 | 6.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.0 | 4.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.0 | 5.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.0 | 5.0 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
1.0 | 1.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.0 | 4.9 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
1.0 | 3.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.0 | 1.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.0 | 2.9 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
1.0 | 5.8 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.0 | 6.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.0 | 4.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.0 | 5.8 | GO:0042168 | heme metabolic process(GO:0042168) |
1.0 | 3.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.0 | 2.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.0 | 2.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.0 | 29.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.0 | 2.9 | GO:0070488 | neutrophil aggregation(GO:0070488) |
1.0 | 1.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.0 | 1.0 | GO:0035973 | aggrephagy(GO:0035973) |
1.0 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.0 | 2.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.9 | 5.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.9 | 3.8 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.9 | 1.9 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.9 | 2.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.9 | 2.8 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.9 | 5.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.9 | 1.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.9 | 2.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.9 | 2.8 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.9 | 1.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.9 | 2.7 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.9 | 0.9 | GO:0001810 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.9 | 0.9 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.9 | 7.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.9 | 3.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.9 | 2.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.9 | 0.9 | GO:0072718 | response to cisplatin(GO:0072718) |
0.9 | 1.8 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.9 | 4.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.9 | 0.9 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.9 | 5.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.9 | 3.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 9.6 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.9 | 1.7 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.9 | 0.9 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.9 | 0.9 | GO:0010159 | specification of organ position(GO:0010159) |
0.9 | 6.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.9 | 3.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.9 | 1.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.9 | 7.8 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.9 | 2.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.9 | 1.7 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.9 | 1.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.9 | 6.8 | GO:0042730 | fibrinolysis(GO:0042730) |
0.9 | 2.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.9 | 2.6 | GO:0033007 | negative regulation of mast cell activation involved in immune response(GO:0033007) |
0.8 | 1.7 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.8 | 2.5 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.8 | 3.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.8 | 0.8 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.8 | 2.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.8 | 6.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.8 | 2.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.8 | 2.5 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.8 | 3.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.8 | 1.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.8 | 4.2 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.8 | 0.8 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.8 | 3.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.8 | 3.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.8 | 0.8 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.8 | 3.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.8 | 3.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.8 | 5.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.8 | 18.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.8 | 12.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.8 | 0.8 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.8 | 1.6 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.8 | 3.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.8 | 3.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.8 | 3.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.8 | 11.5 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.8 | 9.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 1.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.8 | 5.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.8 | 4.0 | GO:0036233 | glycine import(GO:0036233) |
0.8 | 3.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.8 | 2.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.8 | 3.2 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.8 | 6.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.8 | 0.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.8 | 4.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.8 | 0.8 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.8 | 2.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.8 | 3.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.8 | 6.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.8 | 2.4 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.8 | 5.5 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.8 | 4.7 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.8 | 2.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.8 | 0.8 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.8 | 1.6 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.8 | 2.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.8 | 5.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.8 | 0.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.8 | 3.9 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.8 | 2.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.8 | 0.8 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.8 | 0.8 | GO:0034204 | lipid translocation(GO:0034204) |
0.8 | 11.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.8 | 1.5 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.8 | 1.5 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.8 | 3.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.8 | 3.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.8 | 1.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.8 | 2.3 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.8 | 4.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.8 | 2.3 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.8 | 6.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.8 | 3.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.8 | 3.0 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.8 | 2.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.8 | 0.8 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.8 | 15.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.8 | 1.5 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.8 | 4.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.7 | 3.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.7 | 7.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.7 | 6.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 1.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.7 | 0.7 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.7 | 7.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.7 | 1.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.7 | 1.5 | GO:0019081 | viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
0.7 | 12.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.7 | 3.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.7 | 0.7 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.7 | 2.9 | GO:0018214 | protein carboxylation(GO:0018214) |
0.7 | 2.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.7 | 6.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.7 | 5.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.7 | 0.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.7 | 1.4 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.7 | 0.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.7 | 1.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.7 | 0.7 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.7 | 1.4 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.7 | 5.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.7 | 1.4 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.7 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.7 | 2.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.7 | 7.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.7 | 2.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.7 | 2.1 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.7 | 0.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.7 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.7 | 3.5 | GO:0018101 | protein citrullination(GO:0018101) |
0.7 | 1.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.7 | 2.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.7 | 3.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.7 | 3.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.7 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.7 | 3.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 2.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.7 | 1.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.7 | 3.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.7 | 2.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.7 | 1.4 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.7 | 22.0 | GO:0010965 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) metaphase/anaphase transition of cell cycle(GO:0044784) mitotic sister chromatid separation(GO:0051306) |
0.7 | 0.7 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.7 | 2.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.7 | 2.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.7 | 4.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.7 | 1.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.7 | 7.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.7 | 4.8 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.7 | 2.7 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.7 | 5.4 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.7 | 0.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.7 | 6.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.7 | 2.0 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.7 | 0.7 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.7 | 0.7 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.7 | 0.7 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.7 | 2.7 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.7 | 2.7 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.7 | 1.3 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.7 | 2.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.7 | 0.7 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.7 | 20.7 | GO:0006414 | translational elongation(GO:0006414) |
0.7 | 3.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.7 | 4.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.7 | 2.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.7 | 2.0 | GO:0010226 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
0.7 | 2.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 5.3 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.7 | 1.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.7 | 0.7 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.7 | 1.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.7 | 2.6 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.7 | 0.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.7 | 0.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.7 | 3.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.7 | 6.5 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.7 | 6.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.7 | 0.7 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.7 | 7.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.6 | 1.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.6 | 2.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.6 | 2.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 1.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.6 | 1.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 3.8 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 5.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 3.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 1.9 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.6 | 0.6 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.6 | 3.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.6 | 10.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.6 | 3.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.6 | 1.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 1.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.6 | 0.6 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.6 | 3.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.6 | 3.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 7.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 2.5 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.6 | 2.5 | GO:1903205 | regulation of hydrogen peroxide-induced cell death(GO:1903205) |
0.6 | 1.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.6 | 1.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.6 | 4.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.6 | 3.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.6 | 2.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.6 | 2.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.6 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 4.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 3.1 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.6 | 4.9 | GO:0015858 | nucleoside transport(GO:0015858) |
0.6 | 4.3 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.6 | 0.6 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.6 | 1.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.6 | 1.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.6 | 0.6 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.6 | 1.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 2.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.6 | 2.4 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.6 | 3.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.6 | 1.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.6 | 0.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.6 | 1.8 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.6 | 1.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.6 | 1.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.6 | 1.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.6 | 8.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.6 | 2.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.6 | 0.6 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.6 | 7.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.6 | 2.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.6 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.6 | 1.8 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.6 | 4.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 3.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.6 | 1.2 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.6 | 2.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.6 | 0.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.6 | 0.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.6 | 3.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.6 | 0.6 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.6 | 1.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.6 | 2.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 1.2 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.6 | 1.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.6 | 0.6 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.6 | 0.6 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.6 | 0.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 0.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.6 | 1.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 1.7 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.6 | 1.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.6 | 4.0 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.6 | 1.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.6 | 17.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.6 | 2.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.6 | 4.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 0.6 | GO:0050904 | diapedesis(GO:0050904) |
0.6 | 1.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.6 | 15.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.6 | 4.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.6 | 3.4 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.6 | 1.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.6 | 19.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.6 | 3.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.6 | 2.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.6 | 7.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.6 | 2.8 | GO:1904970 | brush border assembly(GO:1904970) |
0.6 | 0.6 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.6 | 1.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.6 | 0.6 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.6 | 1.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.5 | 0.5 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 1.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.5 | 0.5 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.5 | 1.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.5 | 1.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.5 | 2.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.5 | 0.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.5 | 2.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 0.5 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.5 | 3.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.5 | 1.6 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.5 | 8.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 4.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.5 | 3.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 1.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.5 | 3.8 | GO:0031167 | rRNA methylation(GO:0031167) |
0.5 | 1.1 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.5 | 1.6 | GO:0051231 | spindle elongation(GO:0051231) |
0.5 | 9.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.5 | 2.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.5 | 5.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.5 | 4.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.5 | 0.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.5 | 2.1 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.5 | 1.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 2.1 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.5 | 3.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 2.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.5 | 0.5 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.5 | 1.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 2.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 2.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 8.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.5 | 1.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.5 | 1.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.5 | 1.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 1.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.5 | 2.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.5 | 1.5 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.5 | 1.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.5 | 2.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.5 | 5.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.5 | 1.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 1.5 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.5 | 3.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 0.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.5 | 1.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.5 | 3.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.5 | 4.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 3.0 | GO:0006415 | translational termination(GO:0006415) |
0.5 | 2.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.5 | 2.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 5.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.5 | 5.0 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.5 | 1.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.5 | 1.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.5 | 4.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.5 | 3.9 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.5 | 8.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.5 | 3.9 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.5 | 2.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.5 | 1.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.5 | 1.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.5 | 4.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 1.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 1.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.5 | 1.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.5 | 0.5 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.5 | 4.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 5.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.5 | 1.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.5 | 0.5 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.5 | 0.5 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.5 | 1.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.5 | 2.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.5 | 3.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.5 | 0.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.5 | 1.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 1.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.5 | 1.9 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.5 | 1.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.5 | 17.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.5 | 1.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.5 | 2.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.5 | 0.9 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 0.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.5 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.5 | 0.5 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 | 0.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 2.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 0.9 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.5 | 2.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.5 | 1.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 2.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.5 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 2.3 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.5 | 0.9 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.5 | 0.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 0.9 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.5 | 0.5 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.5 | 5.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.5 | 1.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 0.9 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.5 | 3.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.5 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 15.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.5 | 1.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 1.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.4 | 4.0 | GO:0006560 | proline metabolic process(GO:0006560) |
0.4 | 2.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 3.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.4 | 1.3 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.4 | 2.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.4 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 7.1 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.4 | 8.9 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.4 | 2.2 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.4 | 2.7 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 1.8 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 2.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.4 | 1.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 3.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.4 | 11.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.4 | 1.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 10.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 2.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 2.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.4 | 1.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 1.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 0.9 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.4 | 11.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.4 | 1.7 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.4 | 2.2 | GO:0000237 | leptotene(GO:0000237) |
0.4 | 0.9 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.4 | 1.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 1.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.4 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 1.3 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.4 | 3.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.4 | 1.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 2.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.4 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.4 | 0.4 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.4 | 3.4 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.4 | 2.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 3.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.4 | 3.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.4 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 0.8 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 4.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 0.4 | GO:0032736 | positive regulation of interleukin-13 production(GO:0032736) |
0.4 | 13.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.4 | 2.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.4 | 0.4 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.4 | 0.4 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.4 | 1.7 | GO:0045006 | DNA deamination(GO:0045006) |
0.4 | 0.4 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.4 | 1.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 2.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.4 | 1.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 13.6 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.4 | 1.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 2.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 6.2 | GO:0007143 | female meiotic division(GO:0007143) |
0.4 | 0.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 0.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.4 | 2.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 1.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 4.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.4 | 1.6 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.4 | 1.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.4 | 1.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.4 | 2.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.4 | 1.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.4 | 1.2 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.4 | 4.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 6.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 1.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.4 | 2.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.4 | 3.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.4 | 2.0 | GO:0043486 | histone exchange(GO:0043486) |
0.4 | 1.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 0.4 | GO:1902001 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.4 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.4 | 2.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.4 | 2.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 0.4 | GO:0042737 | drug catabolic process(GO:0042737) |
0.4 | 0.8 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.4 | 1.9 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 1.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 0.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 3.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 3.9 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 0.8 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 0.8 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 1.5 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.4 | 1.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 3.4 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.4 | 3.4 | GO:0051168 | nuclear export(GO:0051168) |
0.4 | 1.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 2.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.4 | 0.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 1.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.4 | 0.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 0.8 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.4 | 11.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 0.4 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.4 | 4.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.4 | 8.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.4 | 1.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 0.4 | GO:0060143 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.4 | 1.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.4 | 1.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.4 | 3.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 1.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 0.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.4 | 1.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.4 | 1.8 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.4 | 1.8 | GO:0009642 | response to light intensity(GO:0009642) |
0.4 | 2.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 1.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.4 | 1.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 0.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.4 | 1.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 1.8 | GO:0050779 | RNA destabilization(GO:0050779) |
0.4 | 0.7 | GO:0030421 | defecation(GO:0030421) |
0.4 | 0.7 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.4 | 1.4 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 1.1 | GO:0072678 | T cell migration(GO:0072678) |
0.4 | 10.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 0.7 | GO:0051006 | regulation of lipoprotein lipase activity(GO:0051004) positive regulation of lipoprotein lipase activity(GO:0051006) |
0.4 | 18.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 1.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.4 | 1.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.4 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 1.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 0.4 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.4 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 3.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.4 | 3.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.4 | 1.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.4 | 0.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 8.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.4 | 1.8 | GO:0002836 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.4 | 0.7 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.4 | 6.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.4 | 1.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 1.8 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 | 0.7 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.4 | 3.9 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.4 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 1.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 1.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 1.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.3 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.3 | 1.0 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.3 | 3.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.7 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.3 | 0.3 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.3 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.3 | 1.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 1.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 0.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 1.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 1.0 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.3 | 2.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.3 | 0.7 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.3 | 1.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.3 | 0.7 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.3 | 2.9 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.3 | 1.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.3 | 1.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 3.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 5.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 1.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.3 | 3.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 1.6 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.3 | 1.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 1.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 3.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 6.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 1.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 0.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.3 | 4.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.6 | GO:0070268 | cornification(GO:0070268) |
0.3 | 4.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.3 | 1.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 2.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 1.9 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.3 | 1.3 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.3 | 1.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.3 | 0.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 9.7 | GO:0009060 | aerobic respiration(GO:0009060) |
0.3 | 0.6 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.3 | 0.9 | GO:0035246 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.3 | 4.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 0.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 1.9 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 0.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.3 | 0.9 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 3.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.3 | 1.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 10.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.3 | 2.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 0.9 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 1.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 1.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 0.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 2.4 | GO:0061515 | myeloid cell development(GO:0061515) |
0.3 | 1.2 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.3 | 0.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 0.9 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 0.3 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.3 | 0.9 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 0.9 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.3 | 1.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.6 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 2.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 2.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 1.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 4.2 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.3 | 0.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.3 | 0.9 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 3.6 | GO:0010324 | membrane invagination(GO:0010324) |
0.3 | 0.3 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.3 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.9 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.3 | 1.5 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 1.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 1.7 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 0.6 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.3 | 0.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 3.1 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.3 | 0.6 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.3 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 0.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 0.6 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.3 | 0.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.3 | 1.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 2.5 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.3 | 3.9 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.3 | 1.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.3 | 1.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.3 | 2.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 0.8 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.3 | 1.7 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.3 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 0.6 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 0.8 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 0.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.3 | 0.8 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.3 | 0.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 1.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 2.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 0.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 0.8 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.3 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 0.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 1.9 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.3 | 1.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 0.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.3 | 0.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 0.5 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.3 | 0.3 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.3 | 0.3 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.3 | 5.8 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.3 | 0.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 2.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.3 | 0.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.3 | 0.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.3 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 2.4 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 0.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 3.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 3.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 0.8 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.3 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 1.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.3 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.3 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.3 | 1.3 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.3 | 0.5 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.3 | 0.8 | GO:0090208 | positive regulation of triglyceride catabolic process(GO:0010898) positive regulation of triglyceride metabolic process(GO:0090208) |
0.3 | 2.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.3 | 0.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.3 | 0.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.5 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.3 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.3 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 6.7 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 1.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.2 | 8.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.7 | GO:0032392 | DNA geometric change(GO:0032392) |
0.2 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 8.4 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 0.7 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 1.5 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 1.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 3.4 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.2 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.2 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 2.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.7 | GO:0002328 | pro-B cell differentiation(GO:0002328) regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 3.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 1.0 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 0.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 0.5 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.2 | 0.5 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 1.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 1.9 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 3.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 2.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 2.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.2 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.2 | 7.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 6.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 1.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.2 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.2 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.4 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.2 | 1.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.7 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 3.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 0.4 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.2 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 3.6 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 0.4 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.2 | 0.6 | GO:0009445 | putrescine metabolic process(GO:0009445) putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 1.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.8 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.4 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.2 | 0.4 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 1.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 0.2 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.2 | 0.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.4 | GO:0071826 | ribonucleoprotein complex subunit organization(GO:0071826) |
0.2 | 0.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.6 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.2 | 1.4 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 1.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 4.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.8 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 0.6 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 0.6 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.2 | 0.2 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 1.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.8 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.2 | 2.0 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.8 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 2.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 2.7 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 2.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 2.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 0.6 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.2 | 1.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 2.8 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.2 | 0.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 3.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 8.2 | GO:0007059 | chromosome segregation(GO:0007059) |
0.2 | 0.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 1.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.4 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.2 | 0.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.2 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.2 | 2.2 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 2.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.7 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 1.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 2.5 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.2 | 0.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.2 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.7 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.2 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.2 | 3.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.2 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.2 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 0.3 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.2 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 1.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 1.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 2.2 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.2 | 3.3 | GO:0007098 | centrosome cycle(GO:0007098) |
0.2 | 0.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 1.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 1.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 2.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 2.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.3 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 0.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.6 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.8 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 3.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 0.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.2 | 0.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 3.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 0.2 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.2 | 0.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 1.2 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.2 | 0.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.2 | GO:0019076 | viral release from host cell(GO:0019076) |
0.2 | 1.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.1 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
0.1 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.6 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.1 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.4 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 1.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.1 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.6 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.1 | 5.0 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.7 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 0.6 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.5 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.7 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.4 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 13.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 1.2 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.5 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.1 | 0.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 5.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.6 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.7 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 1.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.5 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.9 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 2.0 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.1 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.3 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.2 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 1.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.6 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.1 | 0.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 3.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.1 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.1 | 0.3 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.9 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.7 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 3.5 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 16.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 1.7 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.1 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.4 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 1.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.1 | GO:0042402 | cellular biogenic amine catabolic process(GO:0042402) |
0.1 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 1.2 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.5 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.3 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.1 | 0.3 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.1 | 0.2 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.1 | 1.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.7 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.6 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 5.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 1.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 7.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.1 | 1.5 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 0.6 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 4.7 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.5 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.1 | 0.3 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.2 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.1 | 1.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.2 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.1 | 0.1 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.2 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 1.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.1 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.3 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.0 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.3 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.0 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.0 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.1 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.0 | 4.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.0 | 1.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.5 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.0 | 0.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 1.2 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.2 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 6.3 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
0.0 | 0.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 1.9 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:1902093 | regulation of sperm motility(GO:1901317) positive regulation of sperm motility(GO:1902093) |
0.0 | 0.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.0 | 0.0 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.0 | 0.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.3 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.0 | 0.5 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 13.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.0 | 0.8 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.0 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.0 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.4 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.0 | 0.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.5 | 37.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
6.5 | 32.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
5.7 | 17.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
5.6 | 33.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
3.2 | 19.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
3.1 | 9.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.9 | 8.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.6 | 7.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.2 | 8.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.2 | 2.2 | GO:0097450 | astrocyte end-foot(GO:0097450) |
2.1 | 6.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.0 | 2.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.9 | 7.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.8 | 9.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.8 | 7.1 | GO:1990130 | Iml1 complex(GO:1990130) |
1.6 | 8.0 | GO:0005579 | membrane attack complex(GO:0005579) |
1.6 | 4.7 | GO:0097413 | Lewy body(GO:0097413) |
1.5 | 4.6 | GO:0031523 | Myb complex(GO:0031523) |
1.5 | 4.6 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.5 | 7.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.5 | 4.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.5 | 8.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.4 | 14.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.4 | 9.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.4 | 5.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.3 | 9.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.3 | 5.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.3 | 8.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.2 | 3.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.2 | 6.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.2 | 7.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.2 | 4.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.2 | 4.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.1 | 9.1 | GO:0001650 | fibrillar center(GO:0001650) |
1.1 | 10.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.1 | 3.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.1 | 4.5 | GO:0005642 | annulate lamellae(GO:0005642) |
1.1 | 5.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.1 | 1.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.1 | 5.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.1 | 4.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.1 | 3.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.1 | 2.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.1 | 10.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.1 | 8.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.1 | 6.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 93.0 | GO:0072562 | blood microparticle(GO:0072562) |
1.0 | 8.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.0 | 4.2 | GO:1990246 | uniplex complex(GO:1990246) |
1.0 | 12.3 | GO:0042581 | specific granule(GO:0042581) |
1.0 | 6.1 | GO:0097342 | ripoptosome(GO:0097342) |
1.0 | 7.0 | GO:0042382 | paraspeckles(GO:0042382) |
1.0 | 4.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.0 | 1.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.0 | 4.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.9 | 0.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.9 | 12.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.9 | 2.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.9 | 10.3 | GO:0042555 | MCM complex(GO:0042555) |
0.9 | 2.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.9 | 14.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.9 | 3.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.9 | 0.9 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.9 | 28.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.9 | 3.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.9 | 2.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.8 | 5.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.8 | 4.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.8 | 11.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 32.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.8 | 11.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 2.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.8 | 2.4 | GO:0000805 | X chromosome(GO:0000805) |
0.8 | 4.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.8 | 3.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.8 | 2.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.8 | 5.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.8 | 0.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.8 | 3.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.8 | 7.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.8 | 5.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.8 | 3.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.8 | 2.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.8 | 14.5 | GO:0045120 | pronucleus(GO:0045120) |
0.8 | 4.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.8 | 7.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.7 | 3.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.7 | 3.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.7 | 31.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.7 | 5.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.7 | 5.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.7 | 8.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.7 | 16.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.7 | 4.4 | GO:0031415 | NatA complex(GO:0031415) |
0.7 | 1.5 | GO:0042627 | chylomicron(GO:0042627) |
0.7 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.7 | 2.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 22.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 1.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.7 | 2.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.7 | 7.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.7 | 14.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.7 | 2.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.7 | 6.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.7 | 18.1 | GO:0008305 | integrin complex(GO:0008305) |
0.7 | 5.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.7 | 9.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.7 | 2.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.7 | 2.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.7 | 3.4 | GO:0000796 | condensin complex(GO:0000796) |
0.7 | 2.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.7 | 3.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.7 | 1.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 10.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.7 | 2.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 9.9 | GO:0000145 | exocyst(GO:0000145) |
0.7 | 1.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.7 | 0.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.7 | 3.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.7 | 5.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 1.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.7 | 2.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.7 | 4.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 42.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.6 | 18.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.6 | 4.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.6 | 2.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.6 | 3.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.6 | 10.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.6 | 2.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.6 | 3.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 8.1 | GO:0010369 | chromocenter(GO:0010369) |
0.6 | 0.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.6 | 0.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.6 | 3.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.6 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.6 | 12.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.6 | 3.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.6 | 6.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 3.0 | GO:0089701 | U2AF(GO:0089701) |
0.6 | 33.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.6 | 2.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 1.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.6 | 12.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.6 | 1.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.6 | 2.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.6 | 1.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.6 | 4.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.6 | 1.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.6 | 2.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 2.2 | GO:0043219 | lateral loop(GO:0043219) |
0.6 | 1.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 8.3 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.6 | 1.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 3.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.5 | 6.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.5 | 1.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.5 | 12.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.5 | 6.0 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 2.7 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 22.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 2.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.5 | 2.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 1.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.5 | 18.2 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 0.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.5 | 1.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 4.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 2.1 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 1.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 5.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.5 | 49.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.5 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 1.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.5 | 12.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 0.5 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.5 | 11.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.5 | 1.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 6.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.5 | 2.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 4.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 1.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.5 | 26.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.5 | 20.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.5 | 2.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.5 | 2.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.5 | 1.9 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 2.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 2.9 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 1.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.5 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 2.4 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.5 | 3.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 1.0 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 1.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.5 | 127.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.5 | 0.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 1.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 1.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.5 | 3.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.5 | 1.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.5 | 1.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 0.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 2.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.5 | 24.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 3.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.5 | 7.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.5 | 6.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.5 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 9.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.5 | 32.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 5.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 2.7 | GO:0070187 | telosome(GO:0070187) |
0.5 | 8.6 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 1.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.4 | 2.2 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 4.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.4 | 0.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 16.0 | GO:0005657 | replication fork(GO:0005657) |
0.4 | 4.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 1.8 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 1.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 0.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 28.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.4 | 1.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 5.6 | GO:0030904 | retromer complex(GO:0030904) |
0.4 | 0.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 1.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.4 | 0.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 1.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 1.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 29.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.4 | 1.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 3.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 1.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.4 | 1.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 2.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.4 | 9.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 38.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 1.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 0.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.4 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 16.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.4 | 21.1 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 17.4 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 19.6 | GO:0098687 | chromosomal region(GO:0098687) |
0.4 | 10.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.4 | 2.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 2.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 24.2 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.4 | 1.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 9.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 29.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 51.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 2.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 2.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 12.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 3.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.4 | 0.4 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 1.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 2.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 3.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 0.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 1.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 2.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 2.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 5.6 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 3.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.3 | 1.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 0.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 2.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 8.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 1.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 2.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 1.6 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 1.9 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 1.5 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 0.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 1.2 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.3 | 3.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 0.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 1.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 4.7 | GO:0005844 | polysome(GO:0005844) |
0.3 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 2.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 2.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 2.6 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.3 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.3 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 7.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 0.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 9.4 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 1.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 2.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.3 | 0.8 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.3 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 2.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 24.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 0.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 10.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 2.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 1.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 3.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 1.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 270.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 4.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 1.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 1.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 3.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 59.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 4.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.4 | GO:0030430 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.2 | 155.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 1.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.8 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 14.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 2.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 7.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 4.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 5.1 | GO:0005819 | spindle(GO:0005819) |
0.2 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 35.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 2.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 7.9 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 5.9 | GO:0031975 | envelope(GO:0031975) |
0.1 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.1 | 31.5 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.5 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 4.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 155.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 2.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 1.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 1.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 6.2 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 2.0 | GO:0005814 | centriole(GO:0005814) |
0.1 | 4.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.1 | GO:0044448 | cell cortex part(GO:0044448) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 4.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 15.5 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 2.5 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.9 | 35.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
4.0 | 27.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.8 | 15.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
3.6 | 10.8 | GO:0019862 | IgA binding(GO:0019862) |
3.5 | 3.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
3.4 | 23.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
3.4 | 20.4 | GO:0004064 | arylesterase activity(GO:0004064) |
3.2 | 12.8 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.2 | 15.9 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
2.9 | 8.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.9 | 8.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.7 | 8.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.6 | 7.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.5 | 10.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.3 | 2.3 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
2.3 | 16.0 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
2.2 | 15.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
2.2 | 6.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.2 | 4.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.1 | 8.6 | GO:0034618 | arginine binding(GO:0034618) |
2.1 | 6.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.1 | 6.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.1 | 8.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
2.1 | 10.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
2.0 | 6.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.0 | 10.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.0 | 6.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.0 | 6.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.0 | 5.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
2.0 | 7.8 | GO:0015232 | heme transporter activity(GO:0015232) |
1.9 | 1.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.9 | 7.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.8 | 5.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.8 | 5.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.8 | 5.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.8 | 5.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.8 | 7.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.8 | 7.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.7 | 14.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.7 | 8.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.7 | 22.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.7 | 5.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.7 | 5.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.7 | 5.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.6 | 1.6 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.6 | 6.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.6 | 12.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.6 | 9.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.6 | 6.2 | GO:0044682 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
1.5 | 13.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.5 | 6.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.5 | 4.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.5 | 4.5 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.5 | 11.9 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.5 | 5.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.5 | 1.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.5 | 29.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.4 | 21.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.4 | 4.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.4 | 25.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.4 | 7.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.4 | 2.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.4 | 8.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.4 | 4.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.4 | 9.6 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
1.4 | 6.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.4 | 1.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.4 | 4.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.4 | 4.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.4 | 4.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.3 | 4.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.3 | 2.6 | GO:0035877 | death effector domain binding(GO:0035877) |
1.3 | 1.3 | GO:0003896 | DNA primase activity(GO:0003896) |
1.3 | 5.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.3 | 3.9 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.3 | 3.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.3 | 3.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.3 | 3.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.3 | 5.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.3 | 10.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.3 | 3.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.3 | 3.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.3 | 3.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.3 | 3.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.3 | 3.8 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.3 | 8.8 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.3 | 5.0 | GO:0043559 | insulin binding(GO:0043559) |
1.3 | 10.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.3 | 3.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.2 | 15.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.2 | 11.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.2 | 1.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.2 | 3.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.2 | 6.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.2 | 4.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.2 | 3.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.2 | 21.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.2 | 6.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.2 | 4.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.2 | 5.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.2 | 3.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.2 | 3.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.2 | 11.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.2 | 6.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.1 | 3.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.1 | 3.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.1 | 6.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.1 | 3.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.1 | 8.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.1 | 5.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.1 | 5.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.1 | 2.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.1 | 5.5 | GO:0016151 | nickel cation binding(GO:0016151) |
1.1 | 4.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.1 | 1.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.1 | 6.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.1 | 1.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.1 | 3.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.1 | 3.3 | GO:0048030 | disaccharide binding(GO:0048030) |
1.1 | 1.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.1 | 4.3 | GO:0051425 | PTB domain binding(GO:0051425) |
1.1 | 5.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.1 | 6.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.1 | 3.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.1 | 6.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
1.1 | 1.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.1 | 6.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.1 | 4.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.1 | 6.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.1 | 5.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.0 | 4.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.0 | 9.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.0 | 1.0 | GO:0050693 | LBD domain binding(GO:0050693) |
1.0 | 13.4 | GO:0005521 | lamin binding(GO:0005521) |
1.0 | 9.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.0 | 3.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.0 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.0 | 3.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.0 | 4.1 | GO:0030984 | kininogen binding(GO:0030984) |
1.0 | 3.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.0 | 6.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.0 | 2.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.0 | 2.0 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
1.0 | 4.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.0 | 3.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.0 | 2.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.0 | 3.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.0 | 1.0 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
1.0 | 6.7 | GO:0005536 | glucose binding(GO:0005536) |
1.0 | 34.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.9 | 4.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 0.9 | GO:0001846 | opsonin binding(GO:0001846) |
0.9 | 2.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.9 | 2.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.9 | 16.7 | GO:0001848 | complement binding(GO:0001848) |
0.9 | 3.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.9 | 4.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.9 | 2.7 | GO:0034862 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.9 | 3.6 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.9 | 8.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.9 | 3.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.9 | 1.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.9 | 3.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.9 | 3.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.9 | 2.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.9 | 6.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.9 | 3.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.9 | 10.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.9 | 2.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.9 | 9.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.9 | 5.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.9 | 26.8 | GO:0043531 | ADP binding(GO:0043531) |
0.9 | 1.7 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.8 | 3.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.8 | 16.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.8 | 2.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.8 | 3.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.8 | 11.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.8 | 1.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.8 | 24.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.8 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.8 | 1.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.8 | 7.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.8 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 2.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.8 | 4.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.8 | 3.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.8 | 7.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.8 | 8.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.8 | 2.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.8 | 3.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.8 | 7.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.8 | 3.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.8 | 2.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.8 | 3.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.8 | 3.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.8 | 8.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.8 | 6.8 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.8 | 2.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.7 | 5.2 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.7 | 4.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 12.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.7 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.7 | 2.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 1.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.7 | 2.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 14.6 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.7 | 19.7 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.7 | 0.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.7 | 2.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.7 | 2.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.7 | 2.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.7 | 4.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.7 | 2.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.7 | 8.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.7 | 1.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.7 | 1.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.7 | 12.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.7 | 8.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.7 | 1.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.7 | 3.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.7 | 6.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.7 | 4.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.7 | 2.1 | GO:0001030 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.7 | 2.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.7 | 7.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.7 | 3.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.7 | 3.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.7 | 2.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.7 | 2.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.7 | 6.9 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.7 | 4.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 2.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.7 | 9.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 4.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.7 | 3.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.7 | 3.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.7 | 2.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.7 | 1.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.7 | 2.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.7 | 2.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 8.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.6 | 4.5 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.6 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.6 | 2.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 11.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.6 | 5.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.6 | 3.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.6 | 4.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.6 | 1.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.6 | 1.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.6 | 2.5 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.6 | 1.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.6 | 8.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.6 | 3.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.6 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.6 | 1.9 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.6 | 2.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.6 | 1.8 | GO:0038100 | nodal binding(GO:0038100) |
0.6 | 8.0 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.6 | 5.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.6 | 5.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.6 | 4.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.6 | 12.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.6 | 1.8 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.6 | 4.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.6 | 21.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.6 | 5.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.6 | 3.5 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.6 | 11.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.6 | 3.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.6 | 5.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 4.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 1.2 | GO:0019961 | interferon binding(GO:0019961) |
0.6 | 4.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.6 | 1.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.6 | 1.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 2.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 7.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.6 | 2.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 1.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 2.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.6 | 1.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.6 | 7.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.6 | 3.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.6 | 3.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.6 | 0.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.6 | 1.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.5 | 1.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.5 | 2.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 5.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.5 | 2.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.5 | 1.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.5 | 18.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.5 | 1.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 5.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.5 | 2.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.5 | 0.5 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.5 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.5 | 2.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 3.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 4.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 2.7 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.5 | 25.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 6.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.5 | 11.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 16.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.5 | 8.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.5 | 2.6 | GO:0015288 | porin activity(GO:0015288) |
0.5 | 1.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 5.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 3.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 2.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 4.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.5 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.5 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 1.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 9.2 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 2.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 18.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.5 | 19.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 5.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 12.6 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 1.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 1.5 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.5 | 3.5 | GO:0090079 | translation activator activity(GO:0008494) translation regulator activity, nucleic acid binding(GO:0090079) |
0.5 | 2.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 54.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 1.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.5 | 2.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.5 | 1.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.5 | 1.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 1.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.5 | 6.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.5 | 2.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.5 | 13.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.5 | 6.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 11.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 3.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 1.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.5 | 1.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 1.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 9.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 4.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 2.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 1.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 1.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 3.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 20.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.5 | 0.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.5 | 6.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.5 | 9.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.5 | 1.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.5 | 0.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.5 | 0.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.5 | 73.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.5 | 0.9 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.5 | 3.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 1.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 2.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 2.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 8.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 8.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.4 | 1.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 1.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 6.5 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.4 | 2.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 0.9 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.4 | 4.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 3.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 5.2 | GO:0071949 | FAD binding(GO:0071949) |
0.4 | 0.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 2.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 0.9 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 2.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 3.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 0.8 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 11.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.4 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 1.3 | GO:0070061 | fructose binding(GO:0070061) |
0.4 | 2.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 9.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.4 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 0.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 5.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 4.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 1.2 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 4.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.4 | 2.9 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.4 | 0.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.4 | 7.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.4 | 2.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 2.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 6.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 1.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 5.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.4 | 23.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.4 | 20.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.4 | 9.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 6.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 10.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.4 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 4.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 1.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.4 | 3.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 4.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 9.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 2.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 1.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 2.0 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.4 | 15.0 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.4 | 5.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 15.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 4.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 19.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 2.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.4 | 4.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.4 | 1.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 1.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 10.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 0.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.4 | 1.9 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.4 | 1.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 2.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 3.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 1.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.4 | 2.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 10.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 1.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 2.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.4 | 2.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 1.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 3.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 6.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 33.7 | GO:0042393 | histone binding(GO:0042393) |
0.4 | 1.5 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 1.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.4 | 1.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 1.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 4.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.4 | 3.3 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.4 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 1.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 1.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.4 | 1.4 | GO:0015925 | galactosidase activity(GO:0015925) |
0.4 | 14.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 4.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 1.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 9.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 3.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 2.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 0.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 31.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 3.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 2.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 45.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.3 | 1.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 0.7 | GO:0015928 | fucosidase activity(GO:0015928) |
0.3 | 1.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 1.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 3.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 2.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 3.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 3.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 1.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.3 | 14.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 0.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 4.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 2.9 | GO:0019213 | deacetylase activity(GO:0019213) |
0.3 | 0.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 1.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 1.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 2.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 25.8 | GO:0004386 | helicase activity(GO:0004386) |
0.3 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 0.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 3.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 1.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 2.8 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 0.6 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 2.4 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 2.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 6.9 | GO:0016749 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.3 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 12.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.3 | 0.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 4.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 6.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 1.5 | GO:0009055 | electron carrier activity(GO:0009055) |
0.3 | 3.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 0.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 5.6 | GO:0052693 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.3 | 2.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 3.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.3 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 2.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 2.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 0.9 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 8.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 1.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 4.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 24.4 | GO:0070735 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.3 | 0.6 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.3 | 1.9 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.3 | 0.6 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.3 | 1.9 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.3 | 0.6 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.3 | 1.9 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 0.8 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.3 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 0.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 5.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 5.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 1.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.3 | 1.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 11.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 0.8 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.8 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 1.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 1.3 | GO:0005048 | signal sequence binding(GO:0005048) |
0.3 | 1.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 4.3 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.3 | 1.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 7.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 5.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 2.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 1.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 5.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 4.1 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.7 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 3.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 0.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.9 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.7 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 2.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 1.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 35.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 17.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.2 | 0.4 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 1.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 5.5 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 107.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 1.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.6 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 5.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 3.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 2.0 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 4.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.5 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 1.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 20.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 2.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.3 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.2 | 0.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 0.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 7.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 3.5 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 2.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 1.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 1.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 2.4 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 3.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 1.6 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 1.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 1.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 5.5 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 4.9 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 3.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.9 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 1.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 7.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 3.9 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.1 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 1.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 2.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.8 | GO:0009975 | cyclase activity(GO:0009975) |
0.0 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 1.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 1.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 34.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.0 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.2 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 19.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.5 | 64.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.5 | 21.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.5 | 44.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.5 | 16.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.4 | 1.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.3 | 10.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.2 | 10.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.1 | 3.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.1 | 23.8 | PID EPO PATHWAY | EPO signaling pathway |
1.0 | 28.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.0 | 41.4 | PID PLK1 PATHWAY | PLK1 signaling events |
1.0 | 6.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.9 | 0.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.9 | 2.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.9 | 5.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.8 | 13.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.8 | 43.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.8 | 8.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.8 | 18.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.8 | 12.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.8 | 29.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.8 | 24.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.7 | 41.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.7 | 22.9 | PID E2F PATHWAY | E2F transcription factor network |
0.7 | 33.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.7 | 16.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 41.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.7 | 13.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.7 | 3.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.7 | 13.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.7 | 14.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 3.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.7 | 8.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.7 | 3.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 4.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 2.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.6 | 3.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.6 | 10.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.6 | 11.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 10.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 2.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 3.4 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 8.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 4.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 7.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 2.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 10.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 41.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.5 | 7.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 1.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 8.1 | PID ATM PATHWAY | ATM pathway |
0.5 | 10.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 5.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 11.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.5 | 19.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 1.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 4.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 0.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 12.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 10.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 11.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 1.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 1.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 6.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 10.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 4.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.4 | 1.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 7.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 8.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 6.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 2.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 3.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 1.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 7.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 3.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 2.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 7.2 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 1.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 2.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 6.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 4.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 3.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 2.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 2.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 3.1 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 42.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 1.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 5.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 1.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 3.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 0.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 2.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 62.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.9 | 3.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
2.8 | 33.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.2 | 2.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
2.2 | 22.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.8 | 9.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.7 | 22.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.7 | 17.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.7 | 28.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.6 | 9.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.6 | 27.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.6 | 4.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.5 | 13.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.5 | 14.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.4 | 9.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.4 | 15.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.3 | 41.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.3 | 2.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.3 | 1.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.3 | 13.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.3 | 14.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.2 | 18.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.2 | 19.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.2 | 9.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.1 | 2.3 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.1 | 33.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.1 | 10.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.1 | 25.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.1 | 12.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.1 | 29.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.0 | 15.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.0 | 9.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.0 | 29.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.0 | 8.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.0 | 17.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.0 | 8.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.0 | 9.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.9 | 19.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.9 | 2.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.9 | 13.8 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.9 | 7.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 8.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.9 | 3.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.9 | 18.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.9 | 12.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.9 | 9.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.9 | 4.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.9 | 32.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.9 | 10.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.9 | 29.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.9 | 6.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.9 | 36.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.9 | 36.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.8 | 12.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.8 | 7.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.8 | 79.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.8 | 15.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 11.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.8 | 12.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.8 | 25.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.8 | 39.9 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.8 | 10.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.8 | 13.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.8 | 6.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.8 | 9.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 8.9 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.7 | 8.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 32.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.7 | 5.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 1.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.7 | 10.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.7 | 2.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.7 | 16.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.7 | 12.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.7 | 16.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.7 | 6.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.7 | 4.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 7.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.7 | 10.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.7 | 4.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.6 | 5.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 1.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.6 | 12.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.6 | 3.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.6 | 4.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.6 | 5.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.6 | 14.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 1.9 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.6 | 1.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.6 | 4.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 3.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.6 | 15.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.6 | 6.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.6 | 8.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 10.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.6 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.6 | 4.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.6 | 1.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 2.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 43.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.6 | 7.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.6 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.6 | 4.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 2.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 7.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 7.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 2.7 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.5 | 9.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.5 | 15.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 8.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 7.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.5 | 3.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 45.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 5.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 1.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.5 | 10.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.5 | 1.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.5 | 4.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.5 | 1.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.5 | 8.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 6.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 5.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 2.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 7.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.5 | 1.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 0.5 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.5 | 17.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.4 | 3.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 3.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 3.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 13.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 1.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 0.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.4 | 10.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 5.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.4 | 5.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.4 | 1.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 6.6 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.4 | 2.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 48.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 3.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 0.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.4 | 5.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 4.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.4 | 29.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.4 | 14.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 5.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 2.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.4 | 3.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 9.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.4 | 6.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.4 | 2.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 5.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 3.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 7.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 36.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 0.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.3 | 2.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 2.7 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.3 | 3.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 2.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 1.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 5.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 7.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 2.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 12.0 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 3.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 0.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 4.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 9.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 1.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 2.9 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.3 | 1.8 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.3 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 4.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 4.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 2.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 7.2 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 2.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 0.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 1.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 6.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 2.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 1.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 4.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 1.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 1.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 5.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 1.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 0.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 2.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 4.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 1.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.8 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 1.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 4.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.2 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 2.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 3.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |